|
Market Cap (5-Jun) $19,084,808 (1,108th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 149,220 |
Shortsold (10-Feb) 15,546 (0.00%) (581st) |
|
52w High $0.059 |
52w Low $0.033 |
P/E 15.29 |
EPS 0 |
RHT released this announcement to the ASX on 24 February 2021, 9:44. The announcement is marked as price sensitive, and is 4 page(s) in length and 252.4kb in size.
You can view all announcements from RHT and see how they appear on a price chart on the announcements page.
At the date of this announcement, RHT was 0.017% short sold according to ASIC data. It was ranked the 546th most shorted stock on the ASX. It remains ranked 581st as of the latest reported data (10 February 2025).
| Other Recent Announcements from RHT | |
|---|---|
| Receipt of R&D Tax Incentive Refund | 30 June 2023, 12:22 |
| Updated HepaFatSmart Cleared by US FDA | 29 June 2023, 11:04 |
| Management Transition | 23 June 2023, 8:18 |
| HepaFat-AI receives CE Marking | 24 February 2021, 9:44 |
| HepaFat-AI Receives TGA Approval | 18 February 2021, 11:19 |
| Trading Halt | 17 February 2021, 14:21 |
| Pause in Trading | 17 February 2021, 14:13 |
You must be logged in to post a reply.
Resonance Health 